Terms: = Sarcomas AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Clinical Outcome
20 results:
1. Enhancing an Oxidative "Trojan Horse" Action of Vitamin C with Arsenic Trioxide for Effective Suppression of kras-Mutant Cancers: A Promising Path at the Bedside.
Burska AN; Ilyassova B; Dildabek A; Khamijan M; Begimbetova D; Molnár F; Sarbassov DD
Cells; 2022 Nov; 11(21):. PubMed ID: 36359850
[TBL] [Abstract] [Full Text] [Related]
2. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract] [Full Text] [Related]
3. ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer.
Reissig TM; Sara L; Ting S; Reis H; Metzenmacher M; Eberhardt WEE; Zaun G; Herold T; Aigner C; Darwiche K; Stuschke M; Schildhaus HU; Schuler M; Wiesweg M
Lung Cancer; 2020 Nov; 149():10-16. PubMed ID: 32947221
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Value of kras Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma.
Tao L; Miao R; Mekhail T; Sun J; Meng L; Fang C; Guan J; Jain A; Du Y; Allen A; Rzeszutko BL; Socinski MA; Chang CC
Clin Lung Cancer; 2021 Jul; 22(4):e506-e511. PubMed ID: 32807653
[TBL] [Abstract] [Full Text] [Related]
5. Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with clinical outcome in Patients with Diverse Cancers.
Subbiah V; Murthy R; Hong DS; Prins RM; Hosing C; Hendricks K; Kolli D; Noffsinger L; Brown R; McGuire M; Fu S; Piha-Paul S; Naing A; Conley AP; Benjamin RS; Kaur I; Bosch ML
Clin Cancer Res; 2018 Aug; 24(16):3845-3856. PubMed ID: 30018119
[No Abstract] [Full Text] [Related]
6. Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.
Yoon S; Rossi JJ
Adv Exp Med Biol; 2017; 983():173-188. PubMed ID: 28639199
[TBL] [Abstract] [Full Text] [Related]
7. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
[TBL] [Abstract] [Full Text] [Related]
8. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract] [Full Text] [Related]
10. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
Song QB; Wang Q; Hu WG
World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
[TBL] [Abstract] [Full Text] [Related]
11. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
Li M; Yu T; Hu YF
Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
[TBL] [Abstract] [Full Text] [Related]
12. Impact of early tumor shrinkage on clinical outcome in wild-type-kras colorectal liver metastases treated with cetuximab.
Ye LC; Wei Y; Zhu DX; Chen T; Xu J
J Gastroenterol Hepatol; 2015 Apr; 30(4):674-9. PubMed ID: 25387601
[TBL] [Abstract] [Full Text] [Related]
13. The frequency of kras and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.
Robertson S; Hyder O; Dodson R; Nayar SK; Poling J; Beierl K; Eshleman JR; Lin MT; Pawlik TM; Anders RA
Hum Pathol; 2013 Dec; 44(12):2768-73. PubMed ID: 24139215
[TBL] [Abstract] [Full Text] [Related]
14. Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer.
Woo J; Palmisiano N; Tester W; Leighton JC
Cancer; 2013 Jun; 119(11):1941-50. PubMed ID: 23504768
[TBL] [Abstract] [Full Text] [Related]
15. Impact of epidermal growth factor receptor and kras mutations on clinical outcome in resected non-small cell lung cancer patients.
Ragusa M; Vannucci J; Ludovini V; Bianconi F; Treggiari S; Tofanetti FR; Flacco A; Colella R; Sidoni A; Crinò L; Puma F
Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969
[TBL] [Abstract] [Full Text] [Related]
16. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
Friedland P; Thomas A; Naran A; Amanuel B; Grieu-Iacopetta F; Carrello A; Harnett G; Meyer C; Phillips M
ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
[TBL] [Abstract] [Full Text] [Related]
17. Effect of kras oncogene substitutions on protein behavior: implications for signaling and clinical outcome.
Ihle NT; Byers LA; Kim ES; Saintigny P; Lee JJ; Blumenschein GR; Tsao A; Liu S; Larsen JE; Wang J; Diao L; Coombes KR; Chen L; Zhang S; Abdelmelek MF; Tang X; Papadimitrakopoulou V; Minna JD; Lippman SM; Hong WK; Herbst RS; Wistuba II; Heymach JV; Powis G
J Natl Cancer Inst; 2012 Feb; 104(3):228-39. PubMed ID: 22247021
[TBL] [Abstract] [Full Text] [Related]
18. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.
García-Foncillas J; Díaz-Rubio E
Clin Transl Oncol; 2010 Aug; 12(8):533-42. PubMed ID: 20709651
[TBL] [Abstract] [Full Text] [Related]
19. Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel.
Menges M; Pees HW
Int J Pancreatol; 1999 Dec; 26(3):193-9. PubMed ID: 10732297
[TBL] [Abstract] [Full Text] [Related]
20. Mutations of the ki-ras oncogene in carcinoma of the endometrium.
Caduff RF; Johnston CM; Frank TS
Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
[TBL] [Abstract] [Full Text] [Related]